Wells Fargo Maintains Overweight on Progyny, Raises Price Target to $38
Benzinga Newsdesk 1 day ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Stan Berenshteyn maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $37 to $38.
Wells Fargo analyst Stan Berenshteyn maintains Progyny (NASDAQ:PGNY) with a Overweight and raises the price target from $37 to $38.